Cargando…
K-RAS4A: Lead or Supporting Role in Cancer Biology?
The RAS oncogene is one of the most frequently mutated genes in human cancer, with K-RAS having a leading role in tumorigenesis. K-RAS undergoes alternative splicing, and as a result its transcript generates two gene products K-RAS4A and K-RAS4B, which are affected by the same oncogenic mutations, a...
Autor principal: | Aran, Veronica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479197/ https://www.ncbi.nlm.nih.gov/pubmed/34604308 http://dx.doi.org/10.3389/fmolb.2021.729830 |
Ejemplares similares
-
Editorial: Ras and Other GTPases in Cancer: From Basic to Applied Research
por: Cho, Kwang-jin, et al.
Publicado: (2021) -
Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity
por: Henkels, Karen M., et al.
Publicado: (2021) -
Nucleotide-Specific Autoinhibition of Full-Length K-Ras4B Identified by Extensive Conformational Sampling
por: Dudas, Balint, et al.
Publicado: (2020) -
Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect
por: He, Xuan, et al.
Publicado: (2022) -
Palmitoylation as a Key Regulator of Ras Localization and Function
por: Busquets-Hernández, Carla, et al.
Publicado: (2021)